Evidence map›Paper›PMID 24843732›Full record

ArticleJournal of diabetes investigation2014

Palmitate induces reactive oxygen species production and β-cell dysfunction by activating nicotinamide adenine dinucleotide phosphate oxidase through Src signaling.

Yuichi Sato, Shimpei Fujimoto, Eri Mukai, Hiroki Sato, Yumiko Tahara, Kasane Ogura, Gen Yamano, Masahito Ogura, Kazuaki Nagashima, Nobuya Inagaki

Open access · hybridAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Tetrahydrocurcumin Attenuates NaIOAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. The Role of Oxidative Stress in Pancreatic β Cell Dysfunction in Diabetes.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yuichi SatoDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Shimpei FujimotoDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan ; Department of Endocrinology, Metabolism and Nephrology Kochi Medical School Kochi University Nankoku Japan.
Eri MukaiDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Hiroki SatoDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Yumiko TaharaDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Kasane OguraDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Gen YamanoDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Masahito OguraDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Kazuaki NagashimaDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Nobuya InagakiDepartment of Diabetes and Clinical Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionChronic hyperlipidemia impairs pancreatic β-cell function, referred to as lipotoxicity. We have reported an important role of endogenous reactive oxygen species (ROS) overproduction by activation of Src, a non-receptor tyrosine kinase, in impaired glucose-induced insulin secretion (GIIS) from diabetic rat islets. In the present study, we investigated the role of ROS production by Src signaling in palmitate-induced dysfunction of β-cells. MATERIALS AND

methodsAfter rat insulinoma INS-1D cells were exposed to 0.6 mmol/L palmitate for 24 h (palmitate exposure); GIIS, ROS production and nicotinamide adenine dinucleotide phosphate oxidase (NOX) activity were examined with or without exposure to10 μmol/L 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2), a Src inhibitior, for 30 or 60 min.

resultsExposure to PP2 recovered impaired GIIS and decreased ROS overproduction as a result of palmitate exposure. Palmitate exposure increased activity of NOX and protein levels of NOX2, a pathological ROS source in β-cells. Palmitate exposure increased the protein level of p47 (phox) , a regulatory protein of NOX2, in membrane fraction compared with control, which was reduced by PP2. Transfection of small interfering ribonucleic acid of p47 (phox) suppressed the augmented p47 (phox) protein level in membrane fraction, decreased augmented ROS production and increased impaired GΙIS by palmitate exposure. In addition, exposure to PP2 ameliorated impaired GIIS and decreased ROS production in isolated islets of KK-A(y) mice, an obese diabetic model with hyperlipidemia.

conclusionsActivation of NOX through Src signaling plays an important role in ROS overproduction and impaired GΙIS caused by chronic exposure to palmitate, suggesting a lipotoxic mechanism of β-cell dysfunction of obese mice.

Indexed as

LipotoxicityPancreatic β‐cellsReactive oxygen species

Identifiers

PMID24843732
PMCPMC4025235
OpenAlexW2166059446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.